The FDA prescribing information does not list menstrual irregularities as a specific adverse effect
Future research should also address optimal dosing, timing of intervention, and potential synergistic or antagonistic interactions with existing immunosuppressive therapiesareas that remain largely unexplored but could have major implications for clinical practice
If you are ever unsure about any part of how to mix Retatrutide, review the steps above or consult your prescribing doctor
Diabetes Obes Metab 2018;20:225563
A 2025 network meta-analysis ranked nausea risk as follows: orforglipron (highest, relative risk 4.77), liraglutide (3.09), semaglutide (2.94), tirzepatide (2.89), exenatide (2.66), and cagrilintide (2.29)
These supplements may also benefit people with muscular diseases and those recovering from knee surgery